Precigen Ownership | Who Owns Precigen?

Overview Forecast RevenueFinancials Chart Transcripts

Precigen Ownership Summary

Precigen is owned by 29.00% institutional investors, 10.52% insiders, and 60.49% retail investors. Patient capital management is the largest institutional shareholder, holding 6.48% of PGEN shares. Patient Opportunity C is the top mutual fund, with 4.63% of its assets in Precigen shares.

PGEN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Precigen	29.00%	10.52%	60.49%
Sector	Healthcare Stocks	279.19%	10.58%	-189.76%
Industry	Biotech Stocks	63.97%	10.68%	25.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Patient capital management	17.88M	6.48%	$20.03M
Blackrock	10.25M	4.11%	$16.19M
Adage capital partners gp	10.87M	3.94%	$12.17M
Blackrock funding, inc. /de	10.38M	3.76%	$11.62M
Vanguard group	8.33M	3.02%	$9.33M
Iridian asset management llc/ct	5.24M	1.90%	$5.87M
Geode capital management	3.30M	1.20%	$3.70M
State street	2.84M	1.14%	$4.49M
Charles schwab investment management	1.28M	0.46%	$1.43M
Northern trust	1.03M	0.41%	$1.63M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Iridian asset management llc/ct	5.24M	1.56%	$5.87M
Patient capital management	17.88M	0.92%	$20.03M
Emfo	519.48K	0.73%	$820.77K
Fore capital	391.81K	0.17%	$438.83K
Lexaurum advisors	691.54K	0.15%	$774.53K
Clarivest asset management	492.15K	0.08%	$777.60K
Gmt capital	668.83K	0.04%	$749.09K
American financial group	66.11K	0.03%	$74.05K
Stoneridge investment partners	68.68K	0.03%	$77.00K
Adage capital partners gp	10.87M	0.02%	$12.17M

Top Buyers

Holder	Shares	% Assets	Change
Iridian asset management llc/ct	5.24M	1.56%	1.47M
Susquehanna group, llp	704.89K	0.00%	655.11K
Lexaurum advisors	691.54K	0.15%	417.06K
Ubs group	421.24K	0.00%	321.72K
Cary street partners financial	87.59K	0.00%	87.59K

Top Sellers

Holder	Shares	% Assets	Change
Opaleye management	-	-	-947.50K
D. e. shaw	424.90K	0.00%	-792.73K
Renaissance	1.07M	0.00%	-532.54K
Tang capital management	-	-	-500.00K
Sanders morris harris	-	-	-363.18K

New Positions

Holder	Shares	% Assets	Change	Value
Cary street partners financial	87.59K	0.00%	87.59K	$98.10K
Group one trading	68.86K	0.00%	68.86K	$77.12M
Allegheny financial group	54.13K	0.02%	54.13K	$60.63K
Vanguard personalized indexing management	29.32K	0.00%	29.32K	$32.84K
Bnp paribas arbitrage, snc	24.35K	-	24.35K	$27.27K

Sold Out

Holder	Change
Capital performance advisors llp	-2.00
Farther finance advisors	-78.00
Creekmur asset management	-98.00
Innealta capital	-99.00
Harbor investment advisory	-125.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	141	6.01%	79,994,349	5.56%	28	3.84%	58	-10.77%	42	44.83%
Dec 31, 2024	69	-47.73%	34,834,421	-53.82%	12	1.41%	32	-40.74%	13	-58.06%
Sep 30, 2024	132	-2.22%	75,430,370	24.15%	29	5.16%	54	-6.90%	31	-20.51%
Jun 30, 2024	133	-0.75%	60,750,666	-1.85%	24	3.95%	58	26.09%	39	-15.22%
Mar 31, 2024	134	-3.60%	61,894,662	-1.03%	24	3.80%	46	-13.21%	46	6.98%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Patient Opportunity C	13.60M	4.63%	-800.00K
Vanguard US Total Market Shares ETF	5.45M	1.85%	-
Vanguard Total Stock Mkt Idx Inv	5.45M	1.85%	-
iShares Russell 2000 ETF	3.44M	1.17%	1.69K
Vanguard Institutional Extnd Mkt Idx Tr	2.30M	0.78%	6.54K
Fidelity Small Cap Index	1.33M	0.45%	33.60K
iShares Russell 2000 Value ETF	1.12M	0.38%	-
iShares Biotechnology ETF	986.28K	0.33%	-4.63K
State St Russell Sm/Mid Cp® Indx NL Cl C	868.39K	0.29%	4.18K
State St Russell Sm/Mid Cp® Indx SL Cl I	868.39K	0.29%	4.18K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 30, 2024	KIRK RANDAL J		Buy	$28.13K
Dec 30, 2024	KIRK RANDAL J		Buy	$12.50M
Aug 09, 2024	Perez Jeffrey Thomas	SVP, IP Affairs	Buy	$50.00K
Aug 09, 2024	KIRK RANDAL J		Buy	$20.00M
Dec 28, 2023	KIRK RANDAL J		Buy	$136.33K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	2	-
2024 Q3	2	-
2024 Q2	-	-

PGEN Ownership FAQ

Who Owns Precigen?

Precigen shareholders are primarily institutional investors at 29.00%, followed by 10.52% insiders and 60.48% retail investors. The average institutional ownership in Precigen's industry, Biotech Stocks , is 63.97%, which Precigen falls below.

Who owns the most shares of Precigen?

Precigen’s largest shareholders are Patient capital management (17.88M shares, 6.48%), Blackrock (10.25M shares, 4.11%), and Adage capital partners gp (10.87M shares, 3.94%). Together, they hold 14.53% of Precigen’s total shares outstanding.

Does Blackrock own Precigen?

Yes, BlackRock owns 4.11% of Precigen, totaling 10.25M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.19M$. In the last quarter, BlackRock decreased its holdings by -116K shares, a -1.12% change.

Who is Precigen’s biggest shareholder by percentage of total assets invested?

Iridian asset management llc/ct is Precigen’s biggest shareholder by percentage of total assets invested, with 1.56% of its assets in 5.24M Precigen shares, valued at 5.87M$.

Who is the top mutual fund holder of Precigen shares?

Patient Opportunity C is the top mutual fund holder of Precigen shares, with 4.63% of its total shares outstanding invested in 13.6M Precigen shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools